(PH) Parker-Hannifin - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7010941042
Stock: Filtration, Sealing, Actuation, Controls, Conveyance
Total Rating 68
Risk 83
Buy Signal -0.48
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.45 |
| Alpha | 25.97 |
| Character TTM | |
|---|---|
| Beta | 1.470 |
| Beta Downside | 1.399 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.79% |
| CAGR/Max DD | 1.73 |
EPS (Earnings per Share)
Revenue
Description: PH Parker-Hannifin February 27, 2026
Parker-Hanifin Corp. (NYSE: PH) designs, manufactures and sells a broad portfolio of motion-control and fluid-handling technologies serving aerospace & defense, industrial equipment, transportation, energy, HVAC/R and related markets worldwide. The business is organized into two primary segments – Diversified Industrial and Aerospace Systems – and sells to OEMs, distributors and directly via its sales force.
In its most recent quarter (Q3 2024), PH reported revenue of $3.6 billion, up 5 % year-over-year, driven by strong demand for hydraulic and electric actuators in the industrial automation space and a rebound in commercial aerospace orders. The company’s operating margin expanded to 13.2 % and its order backlog reached $13.4 billion, reflecting robust pipeline visibility amid rising capital-expenditure budgets in the aerospace and defense sectors.
Key macro drivers include accelerating adoption of electrified power-train components, heightened defense spending in the United States and Europe, and a tightening supply chain for high-purity sealing and filtration products. For a deeper dive into PH’s valuation and how these trends may affect its outlook, you might explore additional analysis on ValueRay.
Headlines to watch out for
- Industrial demand for motion and control technologies drives revenue
- Aerospace and defense spending impacts segment performance
- Raw material and manufacturing costs influence profitability
- Global economic conditions affect industrial and transportation sectors
- Regulatory changes in aerospace and environmental standards pose risks
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 3.54b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.72 > 1.0 |
| NWC/Revenue: 5.41% < 20% (prev 1.81%; Δ 3.60% < -1%) |
| CFO/TA 0.12 > 3% & CFO 3.74b > Net Income 3.54b |
| Net Debt (9.44b) to EBITDA (5.49b): 1.72 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.1m) vs 12m ago -2.03% < -2% |
| Gross Margin: 37.27% > 18% (prev 0.36%; Δ 3.69k% > 0.5%) |
| Asset Turnover: 69.62% > 50% (prev 70.42%; Δ -0.80% > 0%) |
| Interest Coverage Ratio: 11.37 > 6 (EBITDA TTM 5.49b / Interest Expense TTM 402.1m) |
Altman Z'' 5.17
| A: 0.04 (Total Current Assets 7.19b - Total Current Liabilities 6.09b) / Total Assets 30.51b |
| B: 0.75 (Retained Earnings 22.97b / Total Assets 30.51b) |
| C: 0.16 (EBIT TTM 4.57b / Avg Total Assets 29.39b) |
| D: 1.37 (Book Value of Equity 22.16b / Total Liabilities 16.19b) |
| Altman-Z'' Score: 5.17 = AAA |
Beneish M -2.97
| DSRI: 1.09 (Receivables 3.24b/2.89b, Revenue 20.46b/19.91b) |
| GMI: 0.97 (GM 37.27% / 36.19%) |
| AQI: 0.99 (AQ_t 0.67 / AQ_t-1 0.68) |
| SGI: 1.03 (Revenue 20.46b / 19.91b) |
| TATA: -0.01 (NI 3.54b - CFO 3.74b) / TA 30.51b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of PH shares?
As of March 14, 2026, the stock is trading at USD 940.48 with a total of 531,508 shares traded.
Over the past week, the price has changed by -3.67%, over one month by -11.17%, over three months by +0.91% and over the past year by +51.80%.
Over the past week, the price has changed by -3.67%, over one month by -11.17%, over three months by +0.91% and over the past year by +51.80%.
Is PH a buy, sell or hold?
Parker-Hannifin has received a consensus analysts rating of 4.30.
Therefore, it is recommended to buy PH.
- StrongBuy: 14
- Buy: 3
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the PH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1031.4 | 9.7% |
| Analysts Target Price | 1031.4 | 9.7% |
PH Fundamental Data Overview March 13, 2026
P/E Trailing = 34.3617
P/E Forward = 27.8552
P/S = 5.8015
P/B = 8.2946
P/EG = 3.8116
Revenue TTM = 20.46b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 5.49b USD
Long Term Debt = 7.48b USD (from longTermDebt, last quarter)
Short Term Debt = 2.39b USD (from shortTermDebt, last quarter)
Debt = 9.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.44b USD (from netDebt column, last quarter)
Enterprise Value = 128.15b USD (118.70b + Debt 9.87b - CCE 427.0m)
Interest Coverage Ratio = 11.37 (Ebit TTM 4.57b / Interest Expense TTM 402.1m)
EV/FCF = 38.37x (Enterprise Value 128.15b / FCF TTM 3.34b)
FCF Yield = 2.61% (FCF TTM 3.34b / Enterprise Value 128.15b)
FCF Margin = 16.32% (FCF TTM 3.34b / Revenue TTM 20.46b)
Net Margin = 17.29% (Net Income TTM 3.54b / Revenue TTM 20.46b)
Gross Margin = 37.27% ((Revenue TTM 20.46b - Cost of Revenue TTM 12.84b) / Revenue TTM)
Gross Margin QoQ = 37.32% (prev 37.51%)
Tobins Q-Ratio = 4.20 (Enterprise Value 128.15b / Total Assets 30.51b)
Interest Expense / Debt = 1.07% (Interest Expense 106.0m / Debt 9.87b)
Taxrate = 20.58% (219.0m / 1.06b)
NOPAT = 3.63b (EBIT 4.57b * (1 - 20.58%))
Current Ratio = 1.18 (Total Current Assets 7.19b / Total Current Liabilities 6.09b)
Debt / Equity = 0.69 (Debt 9.87b / totalStockholderEquity, last quarter 14.31b)
Debt / EBITDA = 1.72 (Net Debt 9.44b / EBITDA 5.49b)
Debt / FCF = 2.83 (Net Debt 9.44b / FCF TTM 3.34b)
Total Stockholder Equity = 13.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.03% (Net Income 3.54b / Total Assets 30.51b)
RoE = 25.65% (Net Income TTM 3.54b / Total Stockholder Equity 13.79b)
RoCE = 21.49% (EBIT 4.57b / Capital Employed (Equity 13.79b + L.T.Debt 7.48b))
RoIC = 15.45% (NOPAT 3.63b / Invested Capital 23.51b)
WACC = 10.53% (E(118.70b)/V(128.57b) * Re(11.33%) + D(9.87b)/V(128.57b) * Rd(1.07%) * (1-Tc(0.21)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.87%
[DCF] Terminal Value 71.59% ; FCFF base≈3.32b ; Y1≈3.76b ; Y5≈5.08b
[DCF] Fair Price = 385.0 (EV 58.03b - Net Debt 9.44b = Equity 48.59b / Shares 126.2m; r=10.53% [WACC]; 5y FCF grow 15.14% → 2.90% )
EPS Correlation: 92.67 | EPS CAGR: 13.05% | SUE: 1.86 | # QB: 3
Revenue Correlation: 75.37 | Revenue CAGR: 6.50% | SUE: 1.42 | # QB: 3
EPS current Year (2026-06-30): EPS=30.95 | Chg7d=-0.001 | Chg30d=+0.019 | Revisions Net=+24 | Growth EPS=+13.2% | Growth Revenue=+7.2%
EPS next Year (2027-06-30): EPS=34.00 | Chg7d=-0.004 | Chg30d=+0.054 | Revisions Net=+18 | Growth EPS=+9.9% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +0.92 (25 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 8.4% (Discount Rate 11.3% - Earnings Yield 2.9%)
[Growth] Growth Spread = -2.3% (Analyst 6.1% - Implied 8.4%)
P/E Forward = 27.8552
P/S = 5.8015
P/B = 8.2946
P/EG = 3.8116
Revenue TTM = 20.46b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 5.49b USD
Long Term Debt = 7.48b USD (from longTermDebt, last quarter)
Short Term Debt = 2.39b USD (from shortTermDebt, last quarter)
Debt = 9.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.44b USD (from netDebt column, last quarter)
Enterprise Value = 128.15b USD (118.70b + Debt 9.87b - CCE 427.0m)
Interest Coverage Ratio = 11.37 (Ebit TTM 4.57b / Interest Expense TTM 402.1m)
EV/FCF = 38.37x (Enterprise Value 128.15b / FCF TTM 3.34b)
FCF Yield = 2.61% (FCF TTM 3.34b / Enterprise Value 128.15b)
FCF Margin = 16.32% (FCF TTM 3.34b / Revenue TTM 20.46b)
Net Margin = 17.29% (Net Income TTM 3.54b / Revenue TTM 20.46b)
Gross Margin = 37.27% ((Revenue TTM 20.46b - Cost of Revenue TTM 12.84b) / Revenue TTM)
Gross Margin QoQ = 37.32% (prev 37.51%)
Tobins Q-Ratio = 4.20 (Enterprise Value 128.15b / Total Assets 30.51b)
Interest Expense / Debt = 1.07% (Interest Expense 106.0m / Debt 9.87b)
Taxrate = 20.58% (219.0m / 1.06b)
NOPAT = 3.63b (EBIT 4.57b * (1 - 20.58%))
Current Ratio = 1.18 (Total Current Assets 7.19b / Total Current Liabilities 6.09b)
Debt / Equity = 0.69 (Debt 9.87b / totalStockholderEquity, last quarter 14.31b)
Debt / EBITDA = 1.72 (Net Debt 9.44b / EBITDA 5.49b)
Debt / FCF = 2.83 (Net Debt 9.44b / FCF TTM 3.34b)
Total Stockholder Equity = 13.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.03% (Net Income 3.54b / Total Assets 30.51b)
RoE = 25.65% (Net Income TTM 3.54b / Total Stockholder Equity 13.79b)
RoCE = 21.49% (EBIT 4.57b / Capital Employed (Equity 13.79b + L.T.Debt 7.48b))
RoIC = 15.45% (NOPAT 3.63b / Invested Capital 23.51b)
WACC = 10.53% (E(118.70b)/V(128.57b) * Re(11.33%) + D(9.87b)/V(128.57b) * Rd(1.07%) * (1-Tc(0.21)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.87%
[DCF] Terminal Value 71.59% ; FCFF base≈3.32b ; Y1≈3.76b ; Y5≈5.08b
[DCF] Fair Price = 385.0 (EV 58.03b - Net Debt 9.44b = Equity 48.59b / Shares 126.2m; r=10.53% [WACC]; 5y FCF grow 15.14% → 2.90% )
EPS Correlation: 92.67 | EPS CAGR: 13.05% | SUE: 1.86 | # QB: 3
Revenue Correlation: 75.37 | Revenue CAGR: 6.50% | SUE: 1.42 | # QB: 3
EPS current Year (2026-06-30): EPS=30.95 | Chg7d=-0.001 | Chg30d=+0.019 | Revisions Net=+24 | Growth EPS=+13.2% | Growth Revenue=+7.2%
EPS next Year (2027-06-30): EPS=34.00 | Chg7d=-0.004 | Chg30d=+0.054 | Revisions Net=+18 | Growth EPS=+9.9% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +0.92 (25 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 8.4% (Discount Rate 11.3% - Earnings Yield 2.9%)
[Growth] Growth Spread = -2.3% (Analyst 6.1% - Implied 8.4%)